UPDATE 2-FDA places some Seattle Genetics drug trials on hold after 4 deaths

Dec 27 (Reuters) - Seattle Genetics Inc said four

people had died in trials testing its experimental cancer drug,

prompting the U.S. Food and Drug Administration to impose a

clinical hold on several early-stage studies.

Read more